Neoadjuvant Radiochemotherapy

COMBINATION_PRODUCT3 trials

Sponsors

Tianjin Medical University Cancer Institute and Hospital, The First Affiliated Hospital of Zhengzhou University

Conditions

Esophageal Squamous Cell CarcinomaStage II Esophageal CancerStage III Esophageal Cancer

Phase 2

A Phase II Trial to Compare Efficacy and Safety of CRT VS Neo-CRT in Patients Who Achieved CCR for Esophageal Cancer

Tianjin Medical University Cancer Institute and HospitalStage II Esophageal Cancer, Stage III Esophageal Cancer

Start: 2016-09-30End: 2021-09-30Target: 40Updated: 2017-07-18

Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal Squamous Cell Cancer

RecruitingNCT07016724

The First Affiliated Hospital of Zhengzhou UniversityEsophageal Squamous Cell Carcinoma

Start: 2024-08-15End: 2027-08-31Target: 208Updated: 2025-06-12

Phase 3

A Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal Cancer

Tianjin Medical University Cancer Institute and HospitalStage II Esophageal Cancer, Stage III Esophageal Cancer

Start: 2018-12-01End: 2023-12-01Target: 220Updated: 2018-10-16

Related Papers

CCL4 and MIF: Prognostic Biomarkers for Evaluating the Chemoradiotherapy Response and Prognosis in Patients with ESCC

Journal of Cancer2025-03-03

Role of clip markers placed by endoscopic ultrasonography in contouring gross tumor volume for thoracic esophageal squamous cell carcinoma: one prospective study.

2020-09-012 citations